Elicitation of HIV-1-neutralizing antibodies against the CD4-binding site.
about
Current views on the potential for development of a HIV vaccine.Antibodies VRC01 and 10E8 neutralize HIV-1 with high breadth and potency even with Ig-framework regions substantially reverted to germline.Characterization of HIV-1 entry inhibitors with broad activity against R5 and X4 viral strains.Assembly and characterization of gp160-nanodiscs: A new platform for biochemical characterization of HIV envelope spikes.Delineating CD4 dependency of HIV-1: Adaptation to infect low level CD4 expressing target cells widens cellular tropism but severely impacts on envelope functionality.HIV-1 Vaccine-elicited Antibodies Reverted to Their Inferred Naive Germline Reveal Associations between Binding Affinity and in vivo Activation.Rational Design of an Epstein-Barr Virus Vaccine Targeting the Receptor-Binding SiteAntibody Treatment of Ebola and Sudan Virus Infection via a Uniquely Exposed Epitope within the Glycoprotein Receptor-Binding SiteBroadly Neutralizing Antibodies Display Potential for Prevention of HIV-1 Infection of Mucosal Tissue Superior to That of Nonneutralizing Antibodies.Evaluation of a novel multi-immunogen vaccine strategy for targeting 4E10/10E8 neutralizing epitopes on HIV-1 gp41 membrane proximal external region.HIV-1 envelope glycoprotein immunogens to induce broadly neutralizing antibodies.Persistence of VRC01-resistant HIV-1 during antiretroviral therapy.Basis and Statistical Design of the Passive HIV-1 Antibody Mediated Prevention (AMP) Test-of-Concept Efficacy Trials.Increasing the Clinical Potential and Applications of Anti-HIV Antibodies.
P2860
Q30397595-38E0EBC6-76B9-4DCA-A106-B01355929791Q34075820-14790EFD-4AFD-4018-A319-B54CB8AEFBFCQ35441620-9299A453-CBEE-4A07-97FF-A051E0BF7FF1Q36248882-5CF8B3FB-79CA-4986-B3B7-52944F54B6F2Q36298503-F7305098-B130-4C66-8163-0C2E4927B841Q36583109-1C4C648B-F122-435D-B29F-09C8CCD6B078Q36590540-7F008FFC-1BA1-4283-89D0-C3B536F3289BQ36913606-79825E1A-58AD-41CA-8E1F-15FEF2DB250EQ37512871-B066EABF-6AD9-4693-B2DA-91AFC9B3995EQ38405470-1D91F72F-138F-49BA-8ED7-52AD08F08968Q38665463-87E1126B-6DB2-4878-82A7-66FB051871B9Q39036775-3A5DF3BD-3683-455C-911D-AC67FD930993Q46296261-939DAA12-A9A2-4B97-BA08-7EC2D2700F18Q47110966-9CCF6D70-F141-47FD-9A65-C0B034DE1CA0
P2860
Elicitation of HIV-1-neutralizing antibodies against the CD4-binding site.
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Elicitation of HIV-1-neutralizing antibodies against the CD4-binding site.
@ast
Elicitation of HIV-1-neutralizing antibodies against the CD4-binding site.
@en
Elicitation of HIV-1-neutralizing antibodies against the CD4-binding site.
@nl
type
label
Elicitation of HIV-1-neutralizing antibodies against the CD4-binding site.
@ast
Elicitation of HIV-1-neutralizing antibodies against the CD4-binding site.
@en
Elicitation of HIV-1-neutralizing antibodies against the CD4-binding site.
@nl
prefLabel
Elicitation of HIV-1-neutralizing antibodies against the CD4-binding site.
@ast
Elicitation of HIV-1-neutralizing antibodies against the CD4-binding site.
@en
Elicitation of HIV-1-neutralizing antibodies against the CD4-binding site.
@nl
P2093
P2860
P1476
Elicitation of HIV-1-neutralizing antibodies against the CD4-binding site
@en
P2093
Ivelin S Georgiev
M Gordon Joyce
Peter D Kwong
P2860
P304
P356
10.1097/COH.0B013E328363A90E
P577
2013-09-01T00:00:00Z